All 1 tracked stories fall under one category: earnings. Consolidated Water is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Abeona Therapeutics
All 1 tracked stories fall under one category: earnings. Consolidated Water is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.2 for that window. We currently track 1 Finance story that mention Abeona Therapeutics, all published on March 16, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 107 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Abeona Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
Abeona Therapeutics and Consolidated Water are preparing to report full-year 2025 financial results, highlighting contrasting paths in the biotech and utility sectors. While Abeona faces critical regulatory milestones for its gene therapy pipeline, Consolidated Water continues to leverage infrastructure expansion to drive steady revenue growth.
Abeona Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.